Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Galimberti

Showing results (41-50 of 313) with videos related to

Pageof 32
Sort By:
Frontiers in Oncology|January 11, 2020
Precision Medicine in Lymphoma by Innovative Instrumental PlatformsAntonello Di Paolo, Elena Arrigoni, Giacomo Luci, et al.
Acta Haematologica|January 31, 2008
Phenobarbital-associated bone marrow aplasia: a case report and review of the literatureDaniele Focosi, Richard Eric Kast, Edoardo Benedetti, et al.
Leukemia Research|March 6, 2007
NQO1*2 polymorphism and response to treatment in patients with multiple myelomaGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
International Journal of Molecular Sciences|September 25, 2015
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid LeukemiaMarialuisa Polillo, Sara Galimberti, Claudia Baratè, et al.
Frontiers in Oncology|September 27, 2019
Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic ApproachesBarbara Izzo, Enrico Marco Gottardi, Santa Errichiello, et al.
Leukemia Research|November 23, 2006
Folate levels and methylation of CDKI proteinsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
European Journal of Clinical Investigation|July 11, 2012
Impaired function of gamma-delta lymphocytes in melanoma patientsIacopo Petrini, Simone Pacini, Sara Galimberti, et al.
British Journal of Haematology|July 16, 2010
CD23 expression in plasma cell leukaemiaGabriele Buda, Giovanni Carulli, Enrico Orciuolo, et al.
Annals of Hematology|June 2, 2007
Stable low IgG levels in relapsed non-Hodgkin's lymphomasGabriele Buda, Sara Galimberti, Enrico Orciuolo, et al.
European Journal of Haematology|November 4, 2004
Rituximab as treatment for minimal residual disease in hairy cell leukaemiaGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
Pageof 32

Showing results (41-50 of 313) with videos related to

Sort By:
Pageof 32
Frontiers in Oncology|January 11, 2020
Precision Medicine in Lymphoma by Innovative Instrumental PlatformsAntonello Di Paolo, Elena Arrigoni, Giacomo Luci, et al.
Acta Haematologica|January 31, 2008
Phenobarbital-associated bone marrow aplasia: a case report and review of the literatureDaniele Focosi, Richard Eric Kast, Edoardo Benedetti, et al.
Leukemia Research|March 6, 2007
NQO1*2 polymorphism and response to treatment in patients with multiple myelomaGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
International Journal of Molecular Sciences|September 25, 2015
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid LeukemiaMarialuisa Polillo, Sara Galimberti, Claudia Baratè, et al.
Frontiers in Oncology|September 27, 2019
Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic ApproachesBarbara Izzo, Enrico Marco Gottardi, Santa Errichiello, et al.
Leukemia Research|November 23, 2006
Folate levels and methylation of CDKI proteinsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
European Journal of Clinical Investigation|July 11, 2012
Impaired function of gamma-delta lymphocytes in melanoma patientsIacopo Petrini, Simone Pacini, Sara Galimberti, et al.
British Journal of Haematology|July 16, 2010
CD23 expression in plasma cell leukaemiaGabriele Buda, Giovanni Carulli, Enrico Orciuolo, et al.
Annals of Hematology|June 2, 2007
Stable low IgG levels in relapsed non-Hodgkin's lymphomasGabriele Buda, Sara Galimberti, Enrico Orciuolo, et al.
European Journal of Haematology|November 4, 2004
Rituximab as treatment for minimal residual disease in hairy cell leukaemiaGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
Pageof 32